Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Notice bibliographique
Résumé
Position Papers3 April 2001Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseVincenza Snow, MD, Steven Lascher, DVM, MPH, and Christel Mottur-Pilson, PhD, for the Joint Expert Panel on Chronic Obstructive Pulmonary Disease of the American College of Chest Physicians and the American College of Physicians–American Society of Internal Medicine*Vincenza Snow, MD, Steven Lascher, DVM, MPH, and Christel Mottur-Pilson, PhD, for the Joint Expert Panel on Chronic Obstructive Pulmonary Disease of the American College of Chest Physicians and the American College of Physicians–American Society of Internal Medicine*Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-134-7-200104030-00015 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The American College of Physicians–American Society of Internal Medicine (ACP–ASIM) and the American College of Chest Physicians (ACCP) developed this evidence-based clinical practice guideline in collaboration. A joint expert panel examined the evidence and developed recommendations. The numbers in square brackets are cross-references to the numbered sections in the accompanying background paper, "Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence," which is part 2 of this guideline (see pages 600-620). The guideline and background paper are based primarily on a systematic review compiled in an Agency for Healthcare Research and Policy evidence ...References1. Management of acute exacerbations of chronic obstructive pulmonary disease. Evidence Report/Technology Assessment # 19. Agency for Healthcare Research and Quality. AHRQ publication no. 00-E020. Available at: www.ahrq.gov/clinic/copdsum.htm. Google Scholar2. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204. [PMID: 0003492164] LinkGoogle Scholar3. Turner MO, Patel A, Ginsburg S, FitzGerald JM. Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med. 1997;157:1736-44. [PMID: 0009250235] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Vincenza Snow, MD; Steven Lascher, DVM, MPH; Christel Mottur-Pilson, PhDAffiliations: *This paper, written by Vincenza Snow, MD, Steven Lascher, DVM, MPH, and Christel Mottur-Pilson, PhD, was developed by the Joint Expert Panel on Chronic Obstructive Pulmonary Disease of the American College of Chest Physicians (ACCP) and the American College of Physicians–American Society of Internal Medicine (ACP–ASIM): Peter Almenoff, MD; Paul G. Auwaerter, MD; Sidney Braman, MD; Bart Celli, MD; Alan Fein, MD (Co-Chair); Stan Fiel, MD; David Hudgel, MD; Stephanie Levine, MD; Michael Mandel, MD; Sean Tunis, MD, MSc (Co-Chair); Peter Bach, MD; and Steven Lascher, DVM, MPH. Approved by the ACP–ASIM Board of Regents on 16 July 2000 and by the ACCP Board of Directors on 1 July 2000. This paper will also appear in Chest (2001; volume 119).Annals of Internal Medicine encourages readers to copy and distribute this paper, providing such distribution is not for profit. Commercial distribution is not permitted without the express permission of the publisher.Note: Clinical practice guidelines are "guides" only and may not apply to all patients and all clinical situations. Thus, they are not intended to override clinicians' judgment. All ACP–ASIM clinical practice guidelines are considered automatically withdrawn or invalid 5 years after publication or once an update has been issued.Disclaimer: The authors of this article are responsible for its contents, including any clinical or treatment recommendations. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.Corresponding Author: Customer Service, American College of Physicians–American Society of Internal Medicine, 190 N. Independence Mall West, Philadelphia, PA 19106.Current Author Addresses: Drs. Snow, Lascher, and Mottur-Pilson: American College of Physicians–American Society of Internal Medicine, 190 N. Independence Mall West, Philadelphia, PA 19106. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoAcute Exacerbations of Chronic Obstructive Pulmonary Disease Claudia Stey Acute Exacerbations of Chronic Obstructive Pulmonary Disease Michael S. Niederman , Sanjay Sethi , and Fernando Martinez Acute Exacerbations of Chronic Obstructive Pulmonary Disease Vincenza Snow Metrics Cited byBiomarkers as a Prognostic Factor in COPD Exacerbation: A Cohort StudyAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseRisk Factors Associated with Late Failure of Noninvasive Ventilation in Patients with Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease: A Palliative Medicine Review of the Disease, Its Therapies, and Drug InteractionsRecent Advances in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseHow should exacerbations of COPD be managed in the intensive care unit?Inpatient DatabasesComparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational studyWhole-genome methylation profiling of peripheral blood mononuclear cell for acute exacerbations of chronic obstructive pulmonary disease treated with corticosteroidA STUDY OF SERUM MAGNESIUM LEVELS IN PATIENTS WITH ACUTE EXACERBATION OF COPD AND ITS COMPARISON WITH STABLE COPD PATIENTS- A PROSPECTIVE STUDYOutpatient Management for Acute Exacerbations of Obstructive Lung DiseasesC-reactive protein level predicts mortality in COPD: a systematic review and meta-analysisChronic obstructive pulmonary disease: A guide for the primary care physicianAcute Exacerbations of Airway InflammationAcute Exacerbations of Airway InflammationTrends in use and impact on outcome of empiric antibiotic therapy and non-invasive ventilation in COPD patients with acute exacerbationAppropriateness of expectorated sputum cultures in the hospital settingHospital management of acute exacerbations of chronic obstructive pulmonary diseaseAcute Exacerbations of Chronic Obstructive Pulmonary DiseaseReasons for ICU Demand and Long-term Follow-up of a Chronic Obstructive Pulmonary Disease CohortDescompensación respiratoria de la enfermedad pulmonar obstructiva crónicaScompenso respiratorio delle broncopneumopatie croniche ostruttiveEfficacy and Tolerability of Eight Antimicrobial Regimens in the Outpatient Treatment of Exacerbations of Chronic Obstructive Pulmonary DiseaseCigarette Smoke Primes the Pulmonary Environment to IL-1α/CXCR-2–Dependent Nontypeable Haemophilus influenzae –Exacerbated Neutrophilia in MiceReducing the Readmission Burden of COPD: A Focused Review of Recent InterventionsSymptom-Based UltrasonographyA woman with breathlessness: a practical approach to diagnosis and managementTemporal Trends in Hospitalization Rates for Older Adults with Chronic Obstructive Pulmonary DiseaseUse of tiotropium in patients with COPD aged 80 years and olderAssociation Between Antibiotic Treatment and Outcomes in Patients Hospitalized With Acute Exacerbation of COPD Treated With Systemic SteroidsThe Role of Nebulized Therapy in the Management of COPD: Evidence and RecommendationsIn-Hospital DatabasesChronic Obstructive Pulmonary Disease in Older PatientsPulmonary rehabilitation following exacerbations of chronic obstructive pulmonary diseaseDisnea. Insuficiencia respiratoria agudaAntibiotics for exacerbations of chronic obstructive pulmonary diseaseExacerbations of COPDAntibiotic Therapy and Treatment Failure in Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseShort-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPDPrise en charge des exacerbations aiguës de BPCOShort-course fluoroquinolones in acute exacerbations of chronic bronchitisAcute exacerbation of chronic obstructive pulmonary disease in primary care setting in Spain: the EPOCAP studyComparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD)Guidelines Versus Clinical Practice in Antimicrobial Therapy for COPDAnalysis of Hospitalizations for COPD Exacerbation: Opportunities for Improving CareCharacterization of nontypeable Haemophilus influenzae collected from respiratory infections and invasive disease cases in Manitoba, CanadaMethylxanthines for exacerbations of chronic obstructive pulmonary diseaseHow Should Exacerbations of COPD Be Managed in the Intensive Care Unit?Antibiotic Therapy and Treatment Failure in Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseED visit volume and quality of care in acute exacerbations of chronic obstructive pulmonary diseaseEfficacy and Tolerability of Various Antimicrobial Regimens in the Treatment of Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease in OutpatientsPulmonary rehabilitation following exacerbations of chronic obstructive pulmonary diseaseNational Study of Emergency Department Visits for Acute Exacerbation of Chronic Obstructive Pulmonary Disease, 1993-2005Randomized Controlled Trial of an Internet-Based Versus Face-to-Face Dyspnea Self-Management Program for Patients With Chronic Obstructive Pulmonary Disease: Pilot StudyImpact of Guidelines on Antimicrobial Treatment of Respiratory Tract InfectionsAntibiotic Resistance: Modern Principles and Management Strategies to Optimize Outpatient Use of AntibioticsExploratory economic evaluation of patients with COPD on a combination product versus individual components (ipratropium bromide and albuterol)AnaConDa® als Ultima-Ratio-TherapieElectronic Clinical Guidelines for Intensive Care UnitEvaluation of Oxidative Stress and Effectiveness of Low-Dose Glucocorticoid Therapy on Exacerbation of Chronic Obstructive Pulmonary DiseaseCommunity-Acquired Respiratory Complications in the Intensive Care Unit: Pneumonia and Acute Exacerbations of COPDEfficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitisFactors Associated with Hospital Admission among Emergency Department Patients with Chronic Obstructive Pulmonary Disease ExacerbationProcalcitonin-Guided Antibiotic Therapy in COPD ExacerbationsAcute Exacerbations of Chronic Bronchitis in Elderly PatientsThe Quality of Obstructive Lung Disease Care for Adults in the United States as Measured by Adherence to Recommended ProcessesAcute coughReview of Guidelines and the Literature in the Treatment of Acute Bronchospasm in Chronic Obstructive Pulmonary DiseaseAppropriate Use of AntibioticsQuality of Care for Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary DiseasePeter K. Lindenauer, MD, MSc, Penelope Pekow, PhD, Shan Gao, MS, Allison S. Crawford, BA, Benjamin Gutierrez, PhD, and Evan M. Benjamin, MDAntibiotics for exacerbations of chronic obstructive pulmonary diseaseA public health approach to pharmacogenomics and gene-based diagnostic testsRole of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary diseaseCilomilast for COPDPharmacokinetic and Pharmacodynamic Aspects of Oral Moxifloxacin 400 mg/day in Elderly Patients with Acute Exacerbation of Chronic BronchitisReal-Life Treatment of Acute Exacerbations of Chronic Bronchitis with Moxifloxacin or MacrolidesRespiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality – a systematic reviewProcalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]Clinical Significance of the Infection-FreeInterval in the Management of Acute Bacterial Exacerbations of Chronic BronchitisPulmonary rehabilitation following exacerbations of chronic obstructive pulmonary diseaseHospital Treatment of Chronic Obstructive Pulmonary Disease Exacerbations: an Evidence-Based ReviewTratamiento hospitalario de los episodios de agudización de la EPOC. Una revisión basada en la evidenciaA Snapshot of Chronic Obstructive Airways Disease in Australian Emergency DepartmentsIn-hospital Death in Patients With Chronic Obstructive Pulmonary DiseaseIs Internet-based support for dyspnea self-management in patients with chronic obstructive pulmonary disease possible? Results of a pilot studyMaintenance pharmacotherapy of chronic obstructive pulmonary disease: an evidence-based approachEnd-of-Life Content in Treatment Guidelines for Life-Limiting DiseasesKnowledge of guidelines for the management of COPD: a survey of primary care physiciansEditorial Commentary: Who Should Receive Antibiotics for Exacerbations of Chronic Bronchitis? A Plea for More Outcome‐Based StudiesAcute Exacerbation of COPDPharmacologic therapy for acute exacerbations of chronic obstructive pulmonary disease: a reviewL'antibiothérapie dans les exacerbations de BPCO : un traitement permettant d'accepter l'incertitude ?Acute bronchitis: State of the art diagnosis and therapyShort-term and Long-term Outcomes of Moxifloxacin Compared to Standard Antibiotic Treatment in Acute Exacerbations of Chronic BronchitisDoes the Presence of Antibodies Justify the Use of Antibiotics in Exacerbations of Chronic Bronchitis?Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial DesignsEfecto del inmunomodulador AM3 sobre las agudizaciones en enfermos con bronquitis crónica: una revisión sistemática de estudios controladosPerioperative care of the patient with hip fractureGerontologic nurse practitioner care guidelineTreatment of Chronic Obstructive Pulmonary DiseaseAcute Exacerbations of Chronic Obstructive Pulmonary DiseaseOverview of Community-Acquired Respiratory Tract Infections"GOLD" Standards for Acute Exacerbation in COPDEvidence-based approach to acute exacerbations of COPDTiotropium: An Inhaled, Long-Acting Anticholinergic Drug for Chronic Obstructive Pulmonary DiseaseTreatment of acute exacerbations of COPDTratamiento de la enfermedad pulmonar obstructiva crónica (EPOC)Acute Exacerbations in Chronic Obstructive Pulmonary DiseaseInformal Caregiving for Chronic Lung Disease Among Older AmericansPneumonic vs Nonpneumonic Acute Exacerbations of COPDAdvances in hospital medicine: A review of key articles from the literatureTreatment of COPD exacerbationsAcute Exacerbations of Chronic Obstructive Pulmonary DiseaseClaudia Stey, MDAcute Exacerbations of Chronic Obstructive Pulmonary DiseaseMichael S. Niederman, MD, Sanjay Sethi, MD, and Fernando Martinez, MDAppropriate use of antibiotics for respiratory infections: review of recent statements and position papersAcute Exacerbations of Chronic Obstructive Pulmonary DiseaseInternational Respiratory Tract Infection GuidelinesUse of ??-Lactam/??-Lactamase Inhibitor Combinations to Treat Community-Acquired Respiratory Tract InfectionsPolítica de antibióticos en atención primaria y especializada. ¿Dos políticas alejadas?Utilidad de la enseñanza del manejo del cartucho presurizado y el sistema Turbuhaler® en los pacientes hospitalizadosOutcomes in lower respiratory tract infections and the impact of antimicrobial drug resistanceChronic Obstructive Pulmonary DiseaseAntibacterials and Acute Exacerbation of Chronic BronchitisAcute Exacerbation of Chronic Obstructive Pulmonary Diseases: What is the impact of bronchodilators, corticosteroids and antibiotics? 3 April 2001Volume 134, Issue 7Page: 595-599KeywordsAntibioticsBronchodilatorsChronic obstructive pulmonary diseaseDiagnostic radiologyForced expiratory volume in the first second of expirationInpatientsOxygenSputumThoraxTreatment guidelines ePublished: 3 April 2001 Issue Published: 3 April 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,001 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,001 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,000 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,001 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».